Verve Therapeutics, Inc. ( VERV) - Stock Earnings
Stock symbol VERV is outdated, potentially delisted? Maybe it is available on other exchange?
VERV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q3 | -50.1 million USD | 6.9 million USD |
| 2024Q4 | -50.0 million USD | 13.1 million USD |
| 2025Q1 | -31.0 million USD | 33.0 million USD |
VERV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -157.4 million USD | 1.9 million USD |
| 2023 | -200.1 million USD | 11.8 million USD |
| 2024 | -198.7 million USD | 32.3 million USD |
VERV
Price: $11.13
52 week price:
Earnings Per Share: -2.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 434163
Market Capitalization: 994.0 million